All In Biotech

Free tool

FAERS Monitor: Verkazia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214965 or its brand name (Verkazia, Cyclosporine). Reports on generic versions are filed under their own applications.

Reports

57,120

Serious

51,865

91% of reports

Hospitalization

17,526

Death reported

10,991

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use7,916
  • drug ineffective7,861
  • product use in unapproved indication3,634
  • pyrexia2,800
  • diarrhoea2,236
  • condition aggravated2,135
  • nausea2,044
  • pneumonia1,997
  • cytomegalovirus infection1,948
  • hypertension1,724
  • fatigue1,721
  • sepsis1,685
  • rash1,627
  • headache1,601
  • graft versus host disease1,578

Reports by year received

View as table
YearReports
2004881
2005900
20061,029
2007984
20081,675
20091,917
20101,635
20112,284
20121,609
2013733
2014794
2015763
2016955
20171,234
20181,751
20192,425
20203,567
20213,629
20225,338
20235,473
20246,908
20256,091
20264,539

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,997,039 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
graft versus host diseaseSignal1,578103.297.7124,677
cytomegalovirus infectionSignal1,94848.746.580,461
sepsisSignal1,6855.65.46,352
product use in unapproved indicationSignal3,6345.55.313,212
off label useSignal7,9163.43.313,492
hypertensionSignal1,7243.02.92,322
pyrexiaSignal2,8003.02.93,753
condition aggravatedSignal2,1352.62.52,111
pneumoniaSignal1,9972.32.21,446
drug ineffectiveSignal7,8612.22.25,479
rash1,6271.41.3170
diarrhoea2,2361.31.2137
nausea2,0441.00.95
headache1,6010.90.96
fatigue1,7210.80.876

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.